Lambertino MJR, Villegas GSM

Idioma: Español
Referencias bibliográficas: 25
Paginas: 744-754
Archivo PDF: 391.73 Kb.

RESUMEN

Antes de la aparición de la inmunoglobulina antiD muchos fetos de madres negativas para el antígeno “D” resultaban con enfermedad severa. La historia del diagnóstico prenatal de aloinmunización es el perfecto ejemplo del esfuerzo por un diagnóstico constructivo con la finalidad de identificar los casos que requieren tratamiento para disminuir la morbilidad e incrementar la supervivencia mediante el menor número de procedimientos invasivos y reducir sus riesgos asociados. En la actualidad es difícil determinar la prevalencia real de la enfermedad; sin embargo, el entendimiento de la fisiopatología ha ayudado a la evolución de las pruebas diagnósticas y a un mejor enfoque de tratamiento, con repercusión positiva en la evolución de la enfermedad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Blickstein I, Antsaklis A. The different nature of prenatal diagnostics: constructive versus destructive diagnoses. Ultrasound Rev Obstet Gynecol 2004;4:229-231.

2. Kumar B, Ravimohan V, Alfirevic Z. Red-cell alloimmunization. Obstet Gynaecol Reprod Med 2010;20:47-56.

3. Bowman JM. Alloimmune hemolytic disease of the fetus and newborn (erythroblastosis fetalis): diagnosis, management, and prevention. Obstet. IMAGING, Monit. Spec. CONSIDERATIONS. Glob. libr. women’s med; 2008. p. 58.

4. Papantoniou N. Is there any role for cordocentesis and amniocentesis in assessment of Rhesus disease? Ultrasound Rev Obstet Gynecol 2004;4:239-244.

5. Harrison MR. El paciente prenatal: el arte y ciencia de la terapia fetal. 2ª ed. México: McGraw-Hill Interamericana, 2002;790.

6. Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355:156-164.

7. Molina-Giraldo S, Moise KJ. Aloinmunización RH: Manejo anteparto. Revisión de la literatura. Rev Colomb Obstet Ginecol 2009;60:262-273.

8. Moise KJ. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008;112:164-176.

9. Lobato G, Soncini CS. Relationship between obstetric history and Rh(D) alloimmunization severity. Arch Gynecol Obstet 2008;277:245-248.

10. Nordvall M, Dziegiel M, Hegaard HK, Bidstrup M, et al. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion 2009;49:2070-2075.

11. Mari G, Deter RL, Carpenter RL, Rahman F, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000;342:9-14.

12. Avent ND, Madgett TE, Maddocks DG, Soothill PW. Cellfree fetal DNA in the maternal serum and plasma: current and evolving applications. Curr Opin Obstet Gynecol 2009;21:175-179.

13. Hawk AF, Chang EY, Shields SM, Simpson KN. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis. Obstet Gynecol 2013;122:579-585.

14. Goebel JC, Soergel P, Pruggmayer M, Mühlhaus K, et al. Prenatal diagnosis of the Rhesus D fetal blood type on amniotic fluid in daily practice. Arch Gynecol Obstet 2008;277:155-160.

15. Moise KJ. Diagnosing hemolytic disease of the fetus--time to put the needles away? N Engl J Med 2006;355:192-194.

16. Nardozza LM, Moron AF, Araujo Júnior E, Camano L, et al. Rh alloimmunization: Doppler or amniotic fluid analysis in the prediction of fetal anemia? Arch Gynecol Obstet 2007;275:107-711.

17. Lysikiewicz A. Doppler velocimetry in maternal alloimmunization. Doppler Ultrasound Obstet Gynecol 2005;339- 351.

18. Moise KJ. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol 2008;198:161.

19. Mari G, Hanif F. Fetal Doppler: umbilical artery, middle cerebral artery, and venous system. Semin Perinatol 2008;32:253-257.

20. Connan K, Kornman L, Savoia H, Palma-Dias R, et al. IVIG - is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series. Aust N Z J Obstet Gynaecol 2009;49:612-618.

21. Novak DJ, Tyler LN, Reddy RL, Barsoom MJ. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy. J Clin Apher 2008;23:183-185.

22. Urbaniak SJ. Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn. Transfusion 2008;48:2-5.

23. Crowther C, Middleton P. Anti-D administration after childbirth for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2000;CD000021.

24. Woelfer B, Schuchter K, Janisiw M, Hafner E, et al. Postdelivery levels of anti-D IgG prophylaxis in D- mothers depend on maternal body weight. Transfusion 2004;44:512-517.

25. Okwundu CI, Afolabi BB. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy. Cochrane Database Syst Rev Protoc 2013;31:1.